Find Clinical Trial

A factorial randomised trial of blood pressure lowering with a fixed low-dose perindopril-indapamide combination and intensive glucose control with a modified-release gliclazide-based regimen for the prevention of vascular disease among high risk individuals with type 2 diabetes – ADVANCE


← Back
Study Phase

Phase 3

Therapeutic Area

Cardiovascular Diseases

IndicationDiabetes - Type II, Hypertension
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

GLICLAZIDE, INDAPAMIDE, PERINDOPRIL TERT BUTYLAMINE,
S005590,
S005702

Active Substance CodeS005702, S005590
Protocol CodeCL3-05590-013
EudraCT Code2005-003281-41


Documents and links

Results summary READ MORE
Scientific publication READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2022 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility